共 15 条
[10]
Empagliflozin, a novel potent and selective SGLT‐2 inhibitor, improves glycaemic control alone and in combination with insulin in streptozotocin‐induced diabetic rats, a model of type 1 diabetes mellitus[J] . G.Luippold,T.Klein,M.Mark,R.Grempler. Diabetes, Obesity and Metabolism . 2012 (7)